GLG Partners’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

GLG Partners’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-447,289	Closed	-$9.36M	–	524
2016 Q3	$9.36M	Buy	+447,289	New	+$5.15M	0.29%	103

GLG Partners's VTAE Position: Q4 2016 in Review

GLG Partners sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 447,289 shares — an estimated $9.36M sold.

GLG Partners first reported a position in VTAE in Q3 2016 and held it in 1 quarter. The position peaked at $9.36M in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

GLG Partners reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
GLG Partners sold 447,289 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $9.36M.
GLG Partners first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q3 2016 and held it in 1 quarter.
GLG Partners's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $9.36M in Q3 2016.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on GLG Partners's 13F filing for Q4 2016, filed 14 Feb 2017.